Logo image of CGC

CANOPY GROWTH CORP (CGC) Stock Price, Forecast & Analysis

USA - Nasdaq - NASDAQ:CGC - CA1380357048 - Common Stock

1.66 USD
-0.08 (-4.6%)
Last: 12/15/2025, 8:13:50 PM
1.6184 USD
-0.04 (-2.51%)
After Hours: 12/15/2025, 8:13:50 PM

CGC Key Statistics, Chart & Performance

Key Statistics
Market Cap611.64M
Revenue(TTM)278.61M
Net Income(TTM)-385.85M
Shares368.46M
Float341.58M
52 Week High3.07
52 Week Low0.77
Yearly DividendN/A
Dividend Yield0%
EPS(TTM)-2.04
PEN/A
Fwd PEN/A
Earnings (Next)02-05 2026-02-05/bmo
IPO2010-06-04
Sector
GICS SectorHealth Care
GICS IndustryPharmaceuticals
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryPharmaceuticals


CGC short term performance overview.The bars show the price performance of CGC in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 10 20 30 40 50

CGC long term performance overview.The bars show the price performance of CGC in the last 1, 2 and 3 years. 1 year 2 years 3 years -20 -40 -60 -80

The current stock price of CGC is 1.66 USD. In the past month the price increased by 55.14%. In the past year, price decreased by -41.34%.

CANOPY GROWTH CORP / CGC Daily stock chart

CGC Latest News, Press Relases and Analysis

CGC Competitors/Peers

The largest stocks on the US markets in the "Pharmaceuticals" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
LLY ELI LILLY & CO 48.3 1.00T
JNJ JOHNSON & JOHNSON 20.63 516.00B
MRK MERCK & CO. INC. 11.38 248.85B
PFE PFIZER INC 8.26 150.27B
BMY BRISTOL-MYERS SQUIBB CO 8.28 110.52B
ZTS ZOETIS INC 19.08 53.31B
RPRX ROYALTY PHARMA PLC- CL A 9.37 22.24B
VTRS VIATRIS INC 5 13.43B
ELAN ELANCO ANIMAL HEALTH INC 22.6 10.78B
CORT CORCEPT THERAPEUTICS INC 99.2 9.18B
AXSM AXSOME THERAPEUTICS INC N/A 7.37B
BLTE BELITE BIO INC - ADR N/A 4.97B

About CGC

Company Profile

CGC logo image Canopy Growth Corp. engages in the production, distribution, and sale of cannabis and cannabinoid-based products for both adult-use and medical purposes. The company is headquartered in Smiths Falls, Ontario and currently employs 960 full-time employees. The company went IPO on 2010-06-04. The company delivers innovative products with a focus on premium and mainstream cannabis brands, including Doja, 7ACRES, Tweed, and Deep Space, in addition to category-defining vaporizer technology made in Germany by Storz & Bickel. The principal activities of the Company are the production, distribution and sale of a diverse range of cannabis and cannabinoid-based products for both adult-use and medical purposes under a portfolio of distinct brands in Canada. Its Canada cannabis segment includes the production, distribution, and sale of a range of cannabis, hemp, and cannabis related products in Canada. International markets cannabis segment includes the production, distribution, and sale of a range of cannabis and hemp products internationally. Storz & Bickel segment includes the production, distribution, and sale of vaporizers. This Works segment includes the production, distribution and sale of beauty, skincare, wellness and sleep products.

Company Info

CANOPY GROWTH CORP

1 Hershey Dr

Smiths Falls ONTARIO K7A0A8 CA

CEO: David Klein

Employees: 1029

CGC Company Website

CGC Investor Relations

Phone: 18555589333

CANOPY GROWTH CORP / CGC FAQ

Can you describe the business of CANOPY GROWTH CORP?

Canopy Growth Corp. engages in the production, distribution, and sale of cannabis and cannabinoid-based products for both adult-use and medical purposes. The company is headquartered in Smiths Falls, Ontario and currently employs 960 full-time employees. The company went IPO on 2010-06-04. The company delivers innovative products with a focus on premium and mainstream cannabis brands, including Doja, 7ACRES, Tweed, and Deep Space, in addition to category-defining vaporizer technology made in Germany by Storz & Bickel. The principal activities of the Company are the production, distribution and sale of a diverse range of cannabis and cannabinoid-based products for both adult-use and medical purposes under a portfolio of distinct brands in Canada. Its Canada cannabis segment includes the production, distribution, and sale of a range of cannabis, hemp, and cannabis related products in Canada. International markets cannabis segment includes the production, distribution, and sale of a range of cannabis and hemp products internationally. Storz & Bickel segment includes the production, distribution, and sale of vaporizers. This Works segment includes the production, distribution and sale of beauty, skincare, wellness and sleep products.


Can you provide the latest stock price for CANOPY GROWTH CORP?

The current stock price of CGC is 1.66 USD. The price decreased by -4.6% in the last trading session.


Does CANOPY GROWTH CORP pay dividends?

CGC does not pay a dividend.


What is the ChartMill technical and fundamental rating of CGC stock?

CGC has a ChartMill Technical rating of 4 out of 10 and a ChartMill Fundamental rating of 2 out of 10.


Which stock exchange lists CGC stock?

CGC stock is listed on the Nasdaq exchange.


What is CANOPY GROWTH CORP worth?

CANOPY GROWTH CORP (CGC) has a market capitalization of 611.64M USD. This makes CGC a Small Cap stock.


What is the outstanding short interest for CANOPY GROWTH CORP?

The outstanding short interest for CANOPY GROWTH CORP (CGC) is 12.75% of its float.


CGC Technical Analysis

ChartMill assigns a technical rating of 4 / 10 to CGC. When comparing the yearly performance of all stocks, CGC is a bad performer in the overall market: 78.17% of all stocks are doing better.


Chartmill TA Rating
Chartmill Setup Rating

CGC Fundamental Analysis

ChartMill assigns a fundamental rating of 2 / 10 to CGC. While CGC seems to be doing ok healthwise, there are quite some concerns on its profitability.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

CGC Financial Highlights

Over the last trailing twelve months CGC reported a non-GAAP Earnings per Share(EPS) of -2.04. The EPS increased by 58.25% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -36.07%
ROE -52.42%
Debt/Equity 0.33
Chartmill High Growth Momentum
EPS Q2Q%99.32%
Sales Q2Q%5.86%
EPS 1Y (TTM)58.25%
Revenue 1Y (TTM)-0.67%

CGC Forecast & Estimates

13 analysts have analysed CGC and the average price target is 2.72 USD. This implies a price increase of 63.75% is expected in the next year compared to the current price of 1.66.

For the next year, analysts expect an EPS growth of 94.86% and a revenue growth 2.14% for CGC


Analysts
Analysts47.69
Price Target2.72 (63.86%)
EPS Next Y94.86%
Revenue Next Year2.14%

CGC Ownership

Ownership
Inst Owners10.93%
Ins Owners0.18%
Short Float %12.75%
Short Ratio1.81